Skip to main content
Home > BC Innovations > Finance

Chronological Index of : Finance

 Current Issue
  • Kurma chameleon

    How French VC Kurma is bringing industry into tech transfer before creating newcos

    Kurma Partners is using a new model for company creation to pursue disruptive discoveries from academia, with lower risk.

    Published on 1/19/2017
  • Table: Public funding highlights

    IMI branches out Finance Public funding highlights Selected developments and initiatives in 4Q16 from major sources of public funding including National Institutes of Health (NIH), the U.K.'s Medical Research …

    Published on 1/19/2017
  • IMI branches out

    Public funding roundup 4Q16

    IMI incorporates non-profits into its model; A*STAR draws industry partners for joint projects; MJFF awards winners of Parkinson's biomarker contest

    Published on 1/19/2017
  • Starting up stem cells

    How Bayer and Versant are betting on iPS cell therapies with BlueRock startup

    Bayer and Versant are going all-out in regenerative medicine, setting up their newco BlueRock with the funds and connections to put iPS cells in the clinic in two years.

    Published on 12/22/2016
  • Politicizing science

    Why 21st Century Cures is a missed chance for change that will politicize NIH

    21st Century Cures is a missed opportunity to reform NIH that could politicize research and skew grant-making toward short-term projects.

    Published on 12/15/2016
  • Figure: New Public-Private Partnerships (PPPs)

    3Q16 Public-Private Partnership Roundup Finance New Public-Private Partnerships (PPPs) Formation of new PPPs in 3Q16 dropped to its lowest level in two years, reversing an upward trend in the three previous …

    Published on 10/20/2016
  • Table: CDRD's busy year

    3Q16 Public-Private Partnership Roundup Finance CDRD's busy year In the past 12 months, the Centre for Drug Research and Development (CDRD) - Canada's national drug development and commercialization organization - …

    Published on 10/20/2016
  • Table: CDRD's pharma deals

    3Q16 Public-Private Partnership Roundup Finance CDRD's pharma deals The Centre for Drug Research and Development (CDRD) has been an active accelerator for Canadian research and has formed at least seven deals with …

    Published on 10/20/2016
  • 3Q16 Public-Private Partnership Roundup

    Highlights of public-private partnerships from 3Q16

    AZ opens up to Canadian translators; AZ takes epigenetics to the lung with U.K. research groups; Fate and MSKCC ready T cells for the shelf.

    Published on 10/20/2016
  • X-ing out resistance

    Public funding roundup 3Q16

    CARB-X to accelerate antimicrobial resistance products through pipelines; Canadian funding body responds to critics; NHLBI outlines its Strategic Vision.

    Published on 10/6/2016
  • Table: Public funding highlights

    X-ing out resistance Finance Public funding highlights Selected developments and initiatives in 3Q16 from major sources of public funding including National Institutes of Health (NIH), Biomedical Advanced Research …

    Published on 10/6/2016
  • Figure: PPP Consortia

    2Q16 Public-Private Partnership Roundup Finance PPP Consortia

    Published on 8/4/2016
  • Table: Japanese R&D collaborations

    2Q16 Public-Private Partnership Roundup Finance Japanese R&D collaborations To capitalize on Japan's basic research, the country's biopharma companies have announced at least 12 deals with public institutions since…

    Published on 8/4/2016
  • 2Q16 Public-Private Partnership Roundup

    Highlights of public-private partnerships from 2Q16

    Consortia bounce back; Alacris leads a systems biology approach to cancer modeling; GSK to launch infectious disease collaboration at Tsinghua; Chugai backs Osaka's immunology center; Boehringer teams with LDC on …

    Published on 8/4/2016
  • Table: Public funding highlights

    MRCT looks east Finance Public funding highlights Selected developments and initiatives in 2Q16 from major sources of public funding including National Institutes of Health (NIH), the U.K.'s Medical Research …

    Published on 7/28/2016
  • MRCT looks east

    Public funding roundup 2Q16

    MRCT expands its drug development reach to Shanghai; Precision Medicine Initiative opts for Mayo; A*STAR and PE create joint R&D lab; NIH's Open Science finalists.

    Published on 7/28/2016
  • Table: Catalyzing Australian translation

    It takes M2 Finance Catalyzing Australian translation In the last two years, a spate of new publicly funded initiatives have been started in Australia, focused on commercializing technologies or discoveries from …

    Published on 6/30/2016
  • It takes M2

    Two Melbourne universities set up M2 Venture Catalyst to bolster translation

    By creating M2 Venture Catalyst, Monash University and the University of Melbourne are setting up Australia's first-of-its-kind translational asset management fund.

    Published on 6/30/2016
  • Figure: Academic contribution

    Found in translation Finance Academic contribution Proportion of newcos in Europe spun out of academia from 2013 to 2015. Source: BCIQ: BioCentury Online Intelligence

    Published on 5/19/2016
  • Figure: Academic enthusiasm

    Found in translation Finance Academic enthusiasm Academic-focused VC funds in Europe, 2011-15. Funds are categorized by date closed. Sources: Company websites; press releases

    Published on 5/19/2016
  • Figure: Distillery Items 2015

    Found in translation Finance Distillery Items 2015

    Published on 5/19/2016
  • Figure: Distillery Items By Country

    Found in translation Finance Distillery Items By Country Source: BioCentury Archives

    Published on 5/19/2016
  • Figure: Seed and series A funding in Europe

    Found in translation Finance Seed and series A funding in Europe Seed and series A funding received by European companies, 2012-15. Source: BCIQ: BioCentury Online Intelligence

    Published on 5/19/2016
  • Table: Accelerating translation

    Found in translation Finance Accelerating translation Translational organizations founded to commercialize science in Europe. Source: Organization websites, BioCentury Archives Organization Country Year Funding…

    Published on 5/19/2016
  • Table: Top academic spinouts

    Found in translation Finance Top academic spinouts European companies spun out of academia from 2013 to 2015 with more than $20 million in seed or series A funding, that disclosed their first funding during that …

    Published on 5/19/2016

< Previous   1  2  3  4  5  Next >

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993